Back to User profile » Dr Kelli Franzenburg

Papers published by Dr Kelli Franzenburg:


Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm

Citrome L, Franzenburg KR, Suett M, Tohami O, Sharon N, Jehassi A, Harary E, Yu D, Correll CU

Neuropsychiatric Disease and Treatment 2026, 22:534730

Published Date: 8 May 2026

Introducing S.C.O.P.E.™ (Schizophrenia Clinical Outcome Scenarios and Patient–Provider Engagement), an Interactive Digital Platform to Educate Healthcare Professionals on Schizophrenia Care

Correll CU, Rubio JM, Citrome L, Mychaskiw MA, Thompson S, Franzenburg KR, Suett M, Kotak S, Kane JM

Neuropsychiatric Disease and Treatment 2024, 20:1995-2010

Published Date: 19 October 2024

TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia

Citrome L, Suett M, Franzenburg KR, Eshet R, Elgart A, Davis GL 3rd, Harary E, Tohami O, Mychaskiw MA, Kane JM

Neuropsychiatric Disease and Treatment 2024, 20:1901-1917

Published Date: 9 October 2024